J. Goldman & CO LP Protara Therapeutics, Inc. Transaction History
J. Goldman & CO LP
- $3.35 Billion
- Q3 2025
A detailed history of J. Goldman & CO LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 100,350 shares of TARA stock, worth $552,928. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,350
Previous 127,350
21.2%
Holding current value
$552,928
Previous $385,000
13.25%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TARA
# of Institutions
86Shares Held
24.3MCall Options Held
13KPut Options Held
46.4K-
Janus Henderson Group PLC London, X04.23MShares$23.3 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$11.8 Million17.99% of portfolio
-
Blackstone Inc New York, NY1.91MShares$10.5 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.9MShares$10.5 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$9.65 Million3.87% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $62.1M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...